- Home
- CRVS vs GWRS Comparison
CRVS vs GWRS Comparison
Compare CRVS & GWRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- GWRS
- Stock Information
- Founded
- CRVS 2014
- GWRS 2003
- Country
- CRVS United States
- GWRS United States
- Employees
- CRVS N/A
- GWRS N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- GWRS Water Supply
- Sector
- CRVS Health Care
- GWRS Utilities
- Exchange
- CRVS Nasdaq
- GWRS Nasdaq
- Market Cap
- CRVS 305.4M
- GWRS 268.4M
- IPO Year
- CRVS 2016
- GWRS 2010
- Fundamental
- Price
- CRVS $5.55
- GWRS $10.03
- Analyst Decision
- CRVS Strong Buy
- GWRS
- Analyst Count
- CRVS 4
- GWRS 0
- Target Price
- CRVS $15.00
- GWRS N/A
- AVG Volume (30 Days)
- CRVS 461.1K
- GWRS 63.4K
- Earning Date
- CRVS 08-07-2025
- GWRS 08-13-2025
- Dividend Yield
- CRVS N/A
- GWRS 3.03%
- EPS Growth
- CRVS N/A
- GWRS N/A
- EPS
- CRVS N/A
- GWRS 0.22
- Revenue
- CRVS N/A
- GWRS $54,270,000.00
- Revenue This Year
- CRVS N/A
- GWRS $8.31
- Revenue Next Year
- CRVS N/A
- GWRS $6.52
- P/E Ratio
- CRVS N/A
- GWRS $46.06
- Revenue Growth
- CRVS N/A
- GWRS 4.33
- 52 Week Low
- CRVS $2.54
- GWRS $9.37
- 52 Week High
- CRVS $10.00
- GWRS $13.98
- Technical
- Relative Strength Index (RSI)
- CRVS 69.70
- GWRS 52.21
- Support Level
- CRVS $5.03
- GWRS $9.65
- Resistance Level
- CRVS $5.81
- GWRS $9.96
- Average True Range (ATR)
- CRVS 0.32
- GWRS 0.26
- MACD
- CRVS 0.09
- GWRS 0.02
- Stochastic Oscillator
- CRVS 85.22
- GWRS 54.81
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About GWRS Global Water Resources Inc.
Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operates within the State of Arizona.